The estimated Net Worth of Michael W Hilton is at least $1.18 Milion dollars as of 16 August 2024. Mr Hilton owns over 332 units of Accolade stock worth over $582,140 and over the last 4 years he sold ACCD stock worth over $66. In addition, he makes $598,389 as Chief Innovation Officer at Accolade.
Mr has made over 48 trades of the Accolade stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 332 units of ACCD stock worth $1,298 on 16 August 2024.
The largest trade he's ever made was exercising 3,980 units of Accolade stock on 16 June 2022 worth over $15,562. On average, Mr trades about 552 units every 29 days since 2020. As of 16 August 2024 he still owns at least 148,885 units of Accolade stock.
You can see the complete history of Mr Hilton stock trades at the bottom of the page.
Michael W. Hilton is the Chief Innovation Officer at Accolade.
As the Chief Innovation Officer of Accolade, the total compensation of Mr Hilton at Accolade is $598,389. There are 3 executives at Accolade getting paid more, with Rajeev Singh having the highest compensation of $828,000.
Mr Hilton is 56, he's been the Chief Innovation Officer of Accolade since . There are 1 older and 4 younger executives at Accolade. The oldest executive at Accolade, Inc. is J. Michael Cline, 60, who is the Co-Founder & Independent Chairman.
Michael's mailing address filed with the SEC is C/O ACCOLADE, INC., , SEATTLE, WA, 98101.
Over the last 4 years, insiders at Accolade have traded over $9,006,680 worth of Accolade stock and bought 74 units worth $743 . The most active insiders traders include Edgar Jr Bronfman, Jeffrey D Jordan a Dawn G Lepore. On average, Accolade executives and independent directors trade stock every 5 days with the average trade being worth of $18,928. The most recent stock trade was executed by Rajeev Singh on 3 September 2024, trading 3,786 units of ACCD stock currently worth $14,803.
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Accolade executives and other stock owners filed with the SEC include: